BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Young JS, Morshed RA, Kim JW, Balyasnikova IV, Ahmed AU, Lesniak MS. Advances in stem cells, induced pluripotent stem cells, and engineered cells: delivery vehicles for anti-glioma therapy. Expert Opin Drug Deliv 2014;11:1733-46. [PMID: 25005767 DOI: 10.1517/17425247.2014.937420] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Gagliardi M, Cecchini M. Bio-inspired nanoparticles as drug delivery vectors. Nanoparticle Therapeutics 2022. [DOI: 10.1016/b978-0-12-820757-4.00002-8] [Reference Citation Analysis]
2 Li L, Qi Z. Recent Advances in Cell‐Mediated Drug Delivery Systems for Nanomedicine and Imaging. Fundamentals of Drug Delivery 2021. [DOI: 10.1002/9781119769644.ch10] [Reference Citation Analysis]
3 Chang L, Zhang Y, Li M, Zhao X, Wang D, Liu J, Zhou F, Zhang J. Nanostructured lipid carrier co-delivering paclitaxel and doxorubicin restrains the proliferation and promotes apoptosis of glioma stem cells via regulating PI3K/Akt/mTOR signaling. Nanotechnology 2021;32:225101. [PMID: 33690190 DOI: 10.1088/1361-6528/abd439] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Benmelouka AY, Munir M, Sayed A, Attia MS, Ali MM, Negida A, Alghamdi BS, Kamal MA, Barreto GE, Ashraf GM, Meshref M, Bahbah EI. Neural Stem Cell-Based Therapies and Glioblastoma Management: Current Evidence and Clinical Challenges. Int J Mol Sci 2021;22:2258. [PMID: 33668356 DOI: 10.3390/ijms22052258] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Cao J, Zhou H, Yang F, Fan D, Li H, Fan T, Sun P. Zinc Finger E-Box Binding Homeobox 1 Regulates the Biological Behavior of Glioma Cells via iNOS/NF- κ B Signaling. j biomater tissue eng 2021;11:333-8. [DOI: 10.1166/jbt.2021.2549] [Reference Citation Analysis]
6 Ruiz-Garcia H, Alvarado-Estrada K, Krishnan S, Quinones-Hinojosa A, Trifiletti DM. Nanoparticles for Stem Cell Therapy Bioengineering in Glioma. Front Bioeng Biotechnol 2020;8:558375. [PMID: 33365304 DOI: 10.3389/fbioe.2020.558375] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
7 Chastkofsky M, Pituch KC, Katagi H, Ilut L, Xiao T, Han Y, Sonabend AM, Curiel DT, Bonner ER, Nazarian J, Horbinski C, James CD, Saratsis AM, Hashizume R, Lesniak MS, Balyasnikova IV. MSCs Successfully Deliver Oncolytic Virotherapy to Diffuse Intrinsic Pontine Glioma.. [DOI: 10.1101/2020.05.09.085837] [Reference Citation Analysis]
8 Ullah M. Need for Specialized Therapeutic Stem Cells Banks Equipped with Tumor Regression Enzymes and Anti-Tumor Genes. J Biomed Allied Res. 2020;2. [PMID: 33554055 DOI: 10.37191/mapsci-2582-4937-2(1)-013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
9 Su Y, Wang T, Su Y, Li M, Zhou J, Zhang W, Wang W. A neutrophil membrane-functionalized black phosphorus riding inflammatory signal for positive feedback and multimode cancer therapy. Mater Horiz 2020;7:574-85. [DOI: 10.1039/c9mh01068h] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 13.5] [Reference Citation Analysis]
10 Bruinsmann FA, Richter Vaz G, de Cristo Soares Alves A, Aguirre T, Raffin Pohlmann A, Stanisçuaski Guterres S, Sonvico F. Nasal Drug Delivery of Anticancer Drugs for the Treatment of Glioblastoma: Preclinical and Clinical Trials. Molecules 2019;24:E4312. [PMID: 31779126 DOI: 10.3390/molecules24234312] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 17.7] [Reference Citation Analysis]
11 Guerrero-fonseca CA, López-baquero MA, Bedoya-rodríguez AA. Virus oncolíticos: un arma contra el cáncer. Rev Fac Med 2019;67:331-324. [DOI: 10.15446/revfacmed.v67n2.68347] [Reference Citation Analysis]
12 Gagliardi M. Biomimetic and bioinspired nanoparticles for targeted drug delivery. Ther Deliv 2017;8:289-99. [PMID: 28361608 DOI: 10.4155/tde-2017-0013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
13 Bagó JR, Okolie O, Dumitru R, Ewend MG, Parker JS, Werff RV, Underhill TM, Schmid RS, Miller CR, Hingtgen SD. Tumor-homing cytotoxic human induced neural stem cells for cancer therapy. Sci Transl Med 2017;9:eaah6510. [PMID: 28148846 DOI: 10.1126/scitranslmed.aah6510] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 12.8] [Reference Citation Analysis]
14 Zhao XW, Zhan YB, Bao JJ, Zhou JQ, Zhang FJ, Bin Y, Bai YH, Wang YM, Zhang ZY, Liu XZ. Clinicopathological analysis of HOXD4 expression in diffuse gliomas and its correlation with IDH mutations and 1p/19q co-deletion. Oncotarget 2017;8:115657-66. [PMID: 29383189 DOI: 10.18632/oncotarget.23371] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
15 Haynes MT, Huang L. Multistage Delivery Technologies: Multifunctional, Interdisciplinary Approaches to Nanomedicine. Mol Ther 2016;24:849-51. [PMID: 27198852 DOI: 10.1038/mt.2016.75] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
16 Kim J, Murphy J, Chang A, Spencer D, Kane J, Kanojia D, Rashidi A, Young J, Lesniak M. All Aboard. Mesenchymal Stromal Cells as Tumor Stromal Modulators 2017. [DOI: 10.1016/b978-0-12-803102-5.00019-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Erkan EP, Eren E, Genc S, Genc KK. Stem Cell-Based Approaches for Treatment of Glioblastoma. Stem Cells in Clinical Applications 2017. [DOI: 10.1007/978-3-319-33720-3_4] [Reference Citation Analysis]
18 Bagó JR, Alfonso-Pecchio A, Okolie O, Dumitru R, Rinkenbaugh A, Baldwin AS, Miller CR, Magness ST, Hingtgen SD. Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma. Nat Commun 2016;7:10593. [PMID: 26830441 DOI: 10.1038/ncomms10593] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 14.0] [Reference Citation Analysis]
19 Xu YY, Gao P, Sun Y, Duan YR. Development of targeted therapies in treatment of glioblastoma. Cancer Biol Med 2015;12:223-37. [PMID: 26487967 DOI: 10.7497/j.issn.2095-3941.2015.0020] [Cited by in F6Publishing: 28] [Reference Citation Analysis]
20 Bagó JR, Sheets KT, Hingtgen SD. Neural stem cell therapy for cancer. Methods 2016;99:37-43. [PMID: 26314280 DOI: 10.1016/j.ymeth.2015.08.013] [Cited by in Crossref: 32] [Cited by in F6Publishing: 39] [Article Influence: 4.6] [Reference Citation Analysis]
21 Lee UY, Youn YS, Park J, Lee ES. Y-shaped ligand-driven gold nanoparticles for highly efficient tumoral uptake and photothermal ablation. ACS Nano 2014;8:12858-65. [PMID: 25453897 DOI: 10.1021/nn506411q] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 5.8] [Reference Citation Analysis]